Alterations of immune response of non-small cell lung cancer with Azacytidine

Innovative therapies are needed for advanced Non-Small Cell Lung Cancer (NSCLC). We have undertaken a genomics based, hypothesis driving, approach to query an emerging potential that epigenetic therapy may sensitize to immune checkpoint therapy targeting PD-L1/PD-1 interaction. NSCLC cell lines were...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wrangle, John, Wang, Wei, Koch, Alexander, Easwaran, Hariharan, Mohammad, Helai P., Vendetti, Frank, VanCriekinge, Wim, DeMeyer, Tim, Du, Zhengzong, Parsana, Princy, Rodgers, Kristen, Yen, Ray-Whay, Zahnow, Cynthia A., Taube, Janis M., Brahmer, Julie R., Tykodi, Scott S., Easton, Keith, Carvajal, Richard D., Jones, Peter A., Laird, Peter W., Weisenberger, Daniel J., Tsai, Salina, Juergens, Rosalyn A., Topalian, Suzanne L., Rudin, Charles M., Brock, Malcolm V., Pardoll, Drew, Baylin, Stephen B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2013
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3875770/
https://ncbi.nlm.nih.gov/pubmed/24162015
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller